Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada flag Canada · Delayed Price · Currency is CAD
0.8000
-0.0200 (-2.44%)
Jul 24, 2025, 4:00 PM EDT

Thiogenesis Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
36283323--
Market Cap Growth
-9.07%-17.40%48.30%---
Enterprise Value
33233021--
Last Close Price
0.780.600.750.58--
PB Ratio
16.888.066.053.77--
P/TBV Ratio
16.888.066.053.77--
Debt / Equity Ratio
-----0.43-1.04
Quick Ratio
3.097.064.1820.360.180.06
Current Ratio
3.157.144.2320.480.180.15
Return on Equity (ROE)
-102.79%-70.25%-87.95%-159.48%--
Return on Assets (ROA)
-58.97%-39.85%-48.08%-38.51%-738.68%-
Return on Capital (ROIC)
-69.51%-49.96%-56.52%-46.65%--
Earnings Yield
-10.65%-11.39%-15.15%-17.41%--
Buyback Yield / Dilution
-12.59%-15.93%-54.71%-118.86%-15.56%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.